Article Text

Download PDFPDF
Survey of use of probiotics in neonatal units in the UK
  1. Ashok Karupaiah,
  2. Abdulhakim Abdurrazaq,
  3. Josephine Quaynor,
  4. Ammar Abdelhady
  1. Paediatrics and Neonates, Walsall Manor Hospital, Walsall, UK
  1. Correspondence to Dr Ashok Karupaiah, Paediatrics and Neonates, Walsall Manor Hospital, Walsall, WS2 9PS, UK; ashok.karupaiah{at}nhs.net

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We introduced probiotics in Walsall Manor Hospital, a local neonatal unit (LNU) in West Midlands, in February 2022. During the pre-implementation phase, we struggled to find out the extent of use of probiotics in the region. Some units were already using it, some in the process of implementation, some wanted to wait for more evidence. There was no consensus or uniformity on the probiotic strains for use. There was considerable price disparity among the different brands and implementation in some was influenced by the cost of the product.1 2 We decided to follow the European Society for Paediatric Gastroenterology Hepatology and Nutrition recommendations3 for the probiotic strain and introduced ProPrems.

Following our implementation, we conducted a national survey on the current …

View Full Text

Footnotes

  • Contributors AK: conceptualising the survey, writing, editing and reviewing the content. AK also contributed to conduct and analysis of the survey. AbA, JQ and AmA conducted the survey and contributed to analysis of the results.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles